Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis

Background: An optimal sequential systemic therapy for advanced hepatocellular carcinoma (HCC) has not been discovered. We developed a decision model based on available clinical trials to identify an optimal risk/benefit strategy for sequences of novel systemic agents. Methods: A Markov model was bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabibbo, Giuseppe, Celsa, Ciro, Enea, Marco, Battaglia, Salvatore, Rizzo, Giacomo Emanuele Maria, Grimaudo, Stefania, Matranga, Domenica, Attanasio, Massimo, Bruzzi, Paolo, Craxì, Antonio, Cammà, Calogero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464739/
https://www.ncbi.nlm.nih.gov/pubmed/32752060
http://dx.doi.org/10.3390/cancers12082132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464739/
https://www.ncbi.nlm.nih.gov/pubmed/32752060
http://dx.doi.org/10.3390/cancers12082132

Ejemplares similares